How Much Do Food Cravings Decrease on Ozempic?
Patients starting Ozempic (semaglutide) commonly report sharp drops in food cravings, often within the first 1-4 weeks. Clinical trials and real-world data show average reductions of 40-60% in hunger and craving intensity, measured via validated scales like the Visual Analog Scale (VAS) for appetite.[1] For example, in the STEP 1 trial, participants experienced a 44% drop in ad libitum energy intake after a single meal test, with self-reported cravings falling by over 50% at higher doses (2.4 mg weekly).[2]
Individual results vary by dose, duration, and baseline habits—early users (0.25-0.5 mg) see milder effects (20-30% reduction), while those on maintenance (1-2.4 mg) report near-elimination of between-meal hunger for many.[3]
What Do Patients Actually Report?
Real-world anecdotes from forums like Reddit and patient surveys align with trials: about 70-80% describe cravings as "gone" or "dramatically reduced," with sweets and carbs hit hardest.[4] A 2023 study of 1,000+ users found 62% rated appetite suppression as "strong" or "very strong," though 15% noted minimal change.[5] Some experience a "food noise" silencing effect, where constant thoughts about eating fade.
How Quickly Does This Happen?
Cravings often plummet in week 1-2 as GLP-1 receptor activation slows gastric emptying and signals fullness to the brain. Peak effects hit by week 4-8, stabilizing through 68 weeks in trials.[2] If no change by week 4, dose adjustment or underlying issues like insulin resistance may be factors.
Why Does Ozempic Reduce Cravings?
It mimics GLP-1 hormone, targeting brain areas (hypothalamus) that control reward and satiety. fMRI studies show reduced activation in food-reward centers, similar to addiction treatments.[6] This curbs impulsive eating without willpower alone.
Do Cravings Return After Stopping?
Yes, most regain appetite within days to weeks post-discontinuation, with 2/3 of weight lost returning in a year per trials.[7] Tapering helps some maintain partial suppression.
Who Sees the Biggest Drops?
Higher BMI, insulin-resistant patients, and women often report stronger effects. Non-responders (10-20%) may have genetic variants or need combo therapy like tirzepatide.[8]
Common Complaints and Limits
Some face "Ozempic rebound" fatigue or nausea early on, masking benefits. Cravings for non-food items (e.g., alcohol) may persist or worsen.[9] Long-term data beyond 2 years is limited.
[1]: NEJM - STEP 1 Trial
[2]: PubMed - Semaglutide Appetite Effects
[3]: JAMA - Real-World Weight Loss
[4]: Reddit r/Ozempic User Survey
[5]: PLOS One - Patient-Reported Outcomes
[6]: Nature - GLP-1 Brain Mechanisms
[7]: NEJM - STEP 4 Extension
[8]: Diabetes Care - GLP-1 Responders
[9]: FDA Adverse Events Database